Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lara Hathout

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Brachytherapy|September 21, 2025
American Brachytherapy Society (ABS) rectoprostatic gel spacer consensus statementAurelie Garant, Craig E Grossman, Martin T King, et al.
Current Urology Reports|April 5, 2023
Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?Ellen M Cahill, John L Pfail, Melinda Z Fu, et al.
Frontiers in Public Health|June 16, 2023
Radiation therapy for prostate cancer in Syrian refugees: facing the need for changeMehmet Fuat Eren, Sarah S Kilic, Ayfer Ay Eren, et al.
Cancer Medicine|May 7, 2021
Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysisKrupa S Jani, Shou-En Lu, James D Murphy, et al.
Frontiers in Oncology|February 6, 2023
Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapyMutlay Sayan, Lara Hathout, Sarah S Kilic, et al.
Journal of Gastrointestinal Oncology|June 12, 2019
Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicityAndrew Zhang, Matthew P Deek, Sinae Kim, et al.
Clinical Lung Cancer|September 2, 2025
Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung CancerRebecca A Deek, Jongmyung Kim, Ritesh Kumar, et al.
International Journal of Radiation Oncology, Biology, Physics|May 16, 2025
The Prognostic Impact of MLH1 Promoter Hypermethylation in Stage I-II Endometrial Cancer Treated With Adjuvant Radiation Therapy: A Multi-Institutional Retrospective StudyZohaib K Sherwani, Shari Damast, Emma C Fields, et al.
Translational Cancer Research|December 19, 2024
Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancerTheodore Wang, Jongmyung Kim, Ritesh Kumar, et al.
The Prostate|July 18, 2024
PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancerPhilip Sutera, Jongmyung Kim, Ritesh Kumar, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Brachytherapy|September 21, 2025
American Brachytherapy Society (ABS) rectoprostatic gel spacer consensus statementAurelie Garant, Craig E Grossman, Martin T King, et al.
Current Urology Reports|April 5, 2023
Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?Ellen M Cahill, John L Pfail, Melinda Z Fu, et al.
Frontiers in Public Health|June 16, 2023
Radiation therapy for prostate cancer in Syrian refugees: facing the need for changeMehmet Fuat Eren, Sarah S Kilic, Ayfer Ay Eren, et al.
Cancer Medicine|May 7, 2021
Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysisKrupa S Jani, Shou-En Lu, James D Murphy, et al.
Frontiers in Oncology|February 6, 2023
Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapyMutlay Sayan, Lara Hathout, Sarah S Kilic, et al.
Journal of Gastrointestinal Oncology|June 12, 2019
Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicityAndrew Zhang, Matthew P Deek, Sinae Kim, et al.
Clinical Lung Cancer|September 2, 2025
Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung CancerRebecca A Deek, Jongmyung Kim, Ritesh Kumar, et al.
International Journal of Radiation Oncology, Biology, Physics|May 16, 2025
The Prognostic Impact of MLH1 Promoter Hypermethylation in Stage I-II Endometrial Cancer Treated With Adjuvant Radiation Therapy: A Multi-Institutional Retrospective StudyZohaib K Sherwani, Shari Damast, Emma C Fields, et al.
Translational Cancer Research|December 19, 2024
Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancerTheodore Wang, Jongmyung Kim, Ritesh Kumar, et al.
The Prostate|July 18, 2024
PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancerPhilip Sutera, Jongmyung Kim, Ritesh Kumar, et al.
Pageof 6